Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

(2021) Myron S. Cohen   NEW ENGLAND JOURNAL OF MEDICINE

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

(2021) Viviane C Veiga et al.   BMJ-British Medical Journal

Covid-19: Arthritis drug tocilizumab reduces deaths in hospitalised patients, study shows

(2021) Jacqui Wise   BMJ-British Medical Journal

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

(2021) Obbina Abani et al.   LANCET

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Tocilizumab for severe COVID-19: a systematic review and meta-analysis

(2020) Shao-Huan Lan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review

(2020) Saeed K. Alzghari et al.   JOURNAL OF CLINICAL VIROLOGY

A minimal common outcome measure set for COVID-19 clinical research

(2020) John C Marshall et al.   LANCET INFECTIOUS DISEASES

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

(2020) A. Cortegiani et al.   Pulmonology

Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study

(2020) Javier Martínez-Sanz et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

(2020) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

(2020) Shruti Gupta et al.   JAMA Internal Medicine

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

(2020) Olivier Hermine et al.   JAMA Internal Medicine

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

(2020) Carlo Salvarani et al.   JAMA Internal Medicine

Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study

(2020) Benjamin Rossi et al.   Pharmaceuticals

Tocilizumab in hospitalized patients with COVID‐19: Clinical outcomes, inflammatory marker kinetics, and safety

(2020) Joshua A. Hill et al.   JOURNAL OF MEDICAL VIROLOGY

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

(2020) Carlos Salama et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis

(2020) Alejandro Piscoya et al.   PLoS One

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

Methods to estimate the between-study variance and its uncertainty in meta-analysis

(2015) Areti Angeliki Veroniki et al.   Research Synthesis Methods

A tutorial on propensity score estimation for multiple treatments using generalized boosted models

(2013) Daniel F. McCaffrey et al.   STATISTICS IN MEDICINE

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH